Title Associate Professor of Pediatrics Institution Boston Children's Hospital Address Hms Nephrology, Hunnewell-3 300 Longwood Ave Boston MA 02115
|
|

Overview
Major Research Interest:
(a) Roles of different chemokines and chemokine receptors in the progression of human cancers. Recent reports suggest that different chemokines and their receptors play critical role(s) in tumor progression and tumor metastasis. We plan to study the role(s) of oncogenes and some kinases in modulating the expression of different chemokines/chemokine receptors in human breast cancer and renal cancer. Our studies are focused on the signal transduction pathways that are involved in the development and progression of tumor. We have shown that the oncogenic ras pathway can modulate the expression of the splice variants of the chemokine receptor CXCR3, and may play a critical role in the development and rapid progression of cancer (Datta & Pal et al, Cancer Research, 2006).
(b) Mechanism(s) for the development of post-transplantation cancer, and primarily renal and skin cancer. We plan to study the role of different immunosuppressive drugs in modulating the expression of angiogenic cytokines (like vascular endothelial growth factor) and chemokines post-transplantation. We have recently shown that the calcineurin inhibitors (used in transplant patients) can promote rapid progression of human renal cancer through the overexpression of the angiogenic cytokine VEGF (Basu & Pal et al, Cancer Research, 2008; Basu & Pal et al, J Biological Chemistry, 2010). We have also demonstrated that the calcineurin inhibitors can activate the ras oncogenic pathway(s) in human renal cancer cells (Datta & Pal et al, Cancer Research, 2009).
(c) Role of the cytoprotective enzyme heme oxygenase-1 (HO-1) in regulating the expression of different genes for the effective repair mechanism(s) of human renal tubular epithelial cells in response to various shock and injury. We have demonstrated that during renal injury, HO-1 may play a critical role in the repair mechanism(s) by regulating several genes, including angiogenic factors (Laxmanan & Pal et al, J Am Soc of Nephrology, 2005; Datta & Pal et al, Am Journal of Physiology, 2007).

Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R03CA215926
(PAL, SOUMITRO)
Jun 5, 2018 - Jun 30, 2021
CXCR3-B-mediated novel growth-inhibitory signals in breast cancer cells
Role: Principal Investigator
-
R01CA222355
(PAL, SOUMITRO)
Jun 1, 2018 - May 31, 2024
Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer
Role: Principal Investigator
-
R01CA193675
(PAL, SOUMITRO)
Jan 1, 2016 - Dec 31, 2021
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
Role: Principal Investigator
-
R21CA191735
(PAL, SOUMITRO)
Jul 15, 2015 - Jun 30, 2019
Novel Role of Honokiol in Preventing Cancer during Immune Suppression
Role: Principal Investigator
-
R21CA172946
(PAL, SOUMITRO)
Sep 1, 2013 - Aug 31, 2017
Novel Therapeutic Targets For Calcineurin Inhibitor-Induced And mTOR-Mediated Can
Role: Principal Investigator
-
R01CA131145
(PAL, SOUMITRO)
Apr 1, 2009 - Feb 28, 2015
Pathophysiology of Post-Transplantation Cancer
Role: Principal Investigator
-
K01DK064182
(PAL, SOUMITRO)
May 15, 2003 - Mar 31, 2009
VEGF And Renal Inflammation
Role: Principal Investigator

Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.